Latest Breaking News On - Ensign peak advisors inc - Page 7 : comparemela.com

Stoke Therapeutics (NASDAQ:STOK) Trading 4 5% Higher

Stoke Therapeutics (NASDAQ:STOK) Trading 4 5% Higher
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesBarry tichoDorsey whitney trustSecurities exchange commissionHong kong ltdJpmorgan chase coStoke therapeutics incCanaccord genuity groupEnsign peak advisors incGreat west life assurance coStoke therapeuticsGet free reportGenuity groupExchange commissionPeak advisors inc

Stoke Therapeutics (NASDAQ:STOK) Trading 4 5% Higher

Stoke Therapeutics (NASDAQ:STOK) Trading 4 5% Higher
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongStephenj tulipanoJonathan allanYork mellon corpEnsign peak advisors incAmerican international group incSecurities exchange commissionHong kong ltdCantor fitzgeraldGreat west life assurance coNeedham companyJpmorgan chase coStoke therapeutics incStoke therapeuticsGet free report

Altus Power (NYSE:AMPS) Stock Price Down 7 7%

Altus Power (NYSE:AMPS) Stock Price Down 7 7%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesAnthony savinoLars norellRoth mkmMaxim groupManufacturers life insurance companyEdmond de rothschild holdingMorgan stanleyAltus power company profileEnsign peak advisors incAltus power incAltus powerGet free reportPeak advisors incAltus power daily

Meitav Investment House Ltd Has $911,000 Stock Position in Arko Corp (NASDAQ:ARKO)

Meitav Investment House Ltd. trimmed its position in Arko Corp. (NASDAQ:ARKO – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 110,460 shares of the company’s stock after selling 16,565 shares during the quarter. Meitav Investment […]

United statesMorris willnerMeitav investment house ltdEnsign peak advisors incTower research capitalArko corpProshare advisorsSecurities exchange commissionMeitav investment houseFree reportInvestment houseResearch capitalEmployees retirement systemPeak advisors incShare advisorsStock down

Stoke Therapeutics (STOK) Buy Rating Reaffirmed at Needham & Company LLC

Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Needham & Company LLC in a report released on Thursday, Benzinga reports. They presently have a $22.00 price objective on the stock. Needham & Company LLC’s target price indicates a potential upside of 72.41% from the company’s current […]

Hong kongUnited statesJonathan allanStoke therapeutics incCanaccord genuity groupSecurities exchange commissionJpmorgan chase coGreat west life assurance coDorsey whitney trustEnsign peak advisors incHong kong ltdStoke therapeutics company profileNeedham companyStoke therapeuticsGet free reportGenuity group